UA99317C2 - Pharmaceutical composition in tablet form for the treatment of viral diseases - Google Patents

Pharmaceutical composition in tablet form for the treatment of viral diseases

Info

Publication number
UA99317C2
UA99317C2 UAA201007829A UAA201007829A UA99317C2 UA 99317 C2 UA99317 C2 UA 99317C2 UA A201007829 A UAA201007829 A UA A201007829A UA A201007829 A UAA201007829 A UA A201007829A UA 99317 C2 UA99317 C2 UA 99317C2
Authority
UA
Ukraine
Prior art keywords
treatment
pharmaceutical composition
viral diseases
tablet form
aromatizer
Prior art date
Application number
UAA201007829A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Руслан Алексеевич Тищенко
Валентина Ивановна Кобылинская
Татьяна Васильевна Крутских
Людмила Васильевна Безпалько
Евгений Александрович Сова
Анатолий Севастьянович Шаламай
Original Assignee
Публичное Акционерное Общество "Научно-Производственный Центр "Борщаговский Химико-Фармацевтический Завод"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Публичное Акционерное Общество "Научно-Производственный Центр "Борщаговский Химико-Фармацевтический Завод" filed Critical Публичное Акционерное Общество "Научно-Производственный Центр "Борщаговский Химико-Фармацевтический Завод"
Priority to UAA201007829A priority Critical patent/UA99317C2/en
Publication of UA99317C2 publication Critical patent/UA99317C2/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to pharmacy and medicine, in particular to a pharmaceutical composition for the treatment of viral diseases. Tablets according to the invention comprise extract of grey and/or black alder infructescence as active substance, and auxiliary substances such as sorbitol, citrus pectin, citric acid monohydrate, powdered aromatizer, talcum powder, magnesium stearate and sodium saccharin in specified ratio.
UAA201007829A 2010-06-22 2010-06-22 Pharmaceutical composition in tablet form for the treatment of viral diseases UA99317C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201007829A UA99317C2 (en) 2010-06-22 2010-06-22 Pharmaceutical composition in tablet form for the treatment of viral diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201007829A UA99317C2 (en) 2010-06-22 2010-06-22 Pharmaceutical composition in tablet form for the treatment of viral diseases

Publications (1)

Publication Number Publication Date
UA99317C2 true UA99317C2 (en) 2012-08-10

Family

ID=50849091

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201007829A UA99317C2 (en) 2010-06-22 2010-06-22 Pharmaceutical composition in tablet form for the treatment of viral diseases

Country Status (1)

Country Link
UA (1) UA99317C2 (en)

Similar Documents

Publication Publication Date Title
MX2012005365A (en) Immediate release tablet formulations.
MX2012012438A (en) Pharmaceutical formulations comprising pioglitazone and linagliptin.
TR201909173T4 (en) Formulation in fast disintegrating solid dosage form containing functionalized calcium carbonate and its production method.
NZ590291A (en) Pharmaceutical compositions for treatment of parkinson's disease
MX2011013150A (en) Pharmaceutical composition for use in medical and veterinary ophthalmology.
TN2015000135A1 (en) Modified release formulations for oprozomib
MX2012003082A (en) Pharmaceutical compositions for reducing alcohol-induced dose dumping.
PH12014502271A1 (en) Composite formulation comprising multi-unit spheroidal tablet (must) encapsulated in hard capsule and method for preparing same
IL218071A0 (en) Novel pharmaceutical formulations to prevent the misuse of medicinal drugs
WO2010127205A3 (en) Fixed dose drug combination formulations
TN2012000507A1 (en) Enteric tablet
PH12014501408A1 (en) Immediate release multi unit pellet system
MX2021008536A (en) Modified release tablet formulations containing phosphodiesterase inhibitors.
MX2015012109A (en) Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof.
AU2012377476A8 (en) Preparation and method for the prophylaxis and treatment of atypical osteoporosis
PT2389070E (en) Disintegrable formulations of lanthanum carbonate
RU2015113031A (en) The use of 3-n-butyl isoindoline ketones in the preparation of medicines for the prevention and treatment of cerebral infarction
UA99317C2 (en) Pharmaceutical composition in tablet form for the treatment of viral diseases
MX370184B (en) Pharmaceutical composition comprising fingolimod.
WO2012068076A3 (en) Pharmaceutical formulations containing soluble drugs
BR112012020415A2 (en) pharmaceutical composition for the prevention or treatment of osteoarthritis
WO2012141615A3 (en) Medicament
CN102727515A (en) Medicinal preparation for treating dermatophytosis
GR1007299B (en) Original effervescent hydrochloric metformin composition in the form of tablets
WO2013054178A3 (en) Extended release pharmaceutical compositions containing carmabazepine